102 related articles for article (PubMed ID: 7923932)
21. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
[TBL] [Abstract][Full Text] [Related]
22. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.
Landay AL; Mackewicz CE; Levy JA
Clin Immunol Immunopathol; 1993 Oct; 69(1):106-16. PubMed ID: 8403538
[TBL] [Abstract][Full Text] [Related]
23. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
24. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
25. A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry.
Jennings C; Rich K; Siegel JN; Landay A
Clin Immunol Immunopathol; 1994 Apr; 71(1):8-13. PubMed ID: 8137561
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T lymphocytes and progression to AIDS in HIV-infected men: some observations.
Anderson RE; Shiboski SC; Royce R; Jewell NP; Lang W; Winkelstein W
AIDS; 1991 Feb; 5(2):213-5. PubMed ID: 1903262
[TBL] [Abstract][Full Text] [Related]
27. Cytokine network and acute primary HIV-1 infection.
Sinicco A; Biglino A; Sciandra M; Forno B; Pollono AM; Raiteri R; Gioannini P
AIDS; 1993 Sep; 7(9):1167-72. PubMed ID: 8216972
[TBL] [Abstract][Full Text] [Related]
28. Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.
Kalinkovich A; Livshits G; Engelmann H; Harpaz N; Burstein R; Kaminsky M; Wallach D; Bentwich Z
Clin Exp Immunol; 1993 Sep; 93(3):350-5. PubMed ID: 8396513
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of soluble CD8 molecule in patients with lymphatic filariasis.
Lal RB; Ramzy RM; Gad AA
Immunol Lett; 1990 Oct; 26(1):85-8. PubMed ID: 2148926
[TBL] [Abstract][Full Text] [Related]
30. Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes.
Zaunders J; Carr A; McNally L; Penny R; Cooper DA
AIDS; 1995 Jun; 9(6):561-6. PubMed ID: 7662193
[TBL] [Abstract][Full Text] [Related]
31. Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.
Reddy MM; Lange M; Grieco MH
J Clin Microbiol; 1989 Feb; 27(2):257-60. PubMed ID: 2492539
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses.
Kim HS; Degiannis D; Raskova J; Raska K
Clin Immunol Immunopathol; 1991 Jul; 60(1):27-39. PubMed ID: 1904329
[TBL] [Abstract][Full Text] [Related]
33. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.
North ME; Spickett GP; Webster AD; Farrant J
Clin Exp Immunol; 1991 Nov; 86(2):252-5. PubMed ID: 1934593
[TBL] [Abstract][Full Text] [Related]
34. Soluble versus cell-bound CD4, CD8 from bronchoalveolar lavage: correlation with pulmonary diagnoses in human immunodeficiency virus-infected individuals.
Willsie SK; Herndon BL; Miller L; Dew M
J Leukoc Biol; 1996 Jun; 59(6):813-6. PubMed ID: 8691065
[TBL] [Abstract][Full Text] [Related]
35. A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.
Froebel KS; Raab GM; D'Alessandro C; Armitage MP; MacKenzie KM; Struthers M; Whitelaw JM; Yang S
Clin Exp Immunol; 2000 Oct; 122(1):72-8. PubMed ID: 11012621
[TBL] [Abstract][Full Text] [Related]
36. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals.
Chun TW; Justement JS; Sanford C; Hallahan CW; Planta MA; Loutfy M; Kottilil S; Moir S; Kovacs C; Fauci AS
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2464-9. PubMed ID: 14983032
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
38. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
Maimone D; Reder AT
Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
[TBL] [Abstract][Full Text] [Related]
40. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.
Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR
J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
